Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hermann

Showing results (301-310 of 348) with videos related to

Pageof 35
Sort By:
Annals of Clinical and Translational Neurology|November 5, 2019
Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosisMarcel Naumann, Kevin Peikert, Rene Günther, et al.
Stem Cell Reports|January 24, 2018
Isogenic FUS-eGFP iPSC Reporter Lines Enable Quantification of FUS Stress Granule Pathology that Is Rescued by Drugs Inducing AutophagyLara Marrone, Ina Poser, Ian Casci, et al.
Brain : a Journal of Neurology|February 28, 2026
Constitutive neuronal expression and disease-associated upregulation of chitinases in amyotrophic lateral sclerosisNayana Gaur, Christin Angerer, Zeynep I Gunes, et al.
Annals of Clinical and Translational Neurology|April 1, 2021
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatmentMaren Freigang, Claudia D Wurster, Tim Hagenacker, et al.
Cell Reports. Medicine|May 4, 2024
Targeting low levels of MIF expression as a potential therapeutic strategy for ALSLeenor Alfahel, Thomas Gschwendtberger, Velina Kozareva, et al.
Annals of Clinical and Translational Neurology|February 22, 2022
Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophyCamilla Binz, Alma Osmanovic, Nele H Thomas, et al.
Annals of Clinical and Translational Neurology|July 30, 2019
KCNC1-related disorders: new de novo variants expand the phenotypic spectrumJoohyun Park, Mahmoud Koko, Ulrike B S Hedrich, et al.
The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.
Stem Cells (Dayton, Ohio)|March 7, 2016
4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem CellsMaximilian Naujock, Nancy Stanslowsky, Sebastian Bufler, et al.
Journal of Neurology|May 6, 2018
Therapeutic decisions in ALS patients: cross-cultural differences and clinical implicationsPeter M Andersen, Magdalena Kuzma-Kozakiewicz, Jürgen Keller, et al.
Pageof 35

Showing results (301-310 of 348) with videos related to

Sort By:
Pageof 35
Annals of Clinical and Translational Neurology|November 5, 2019
Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosisMarcel Naumann, Kevin Peikert, Rene Günther, et al.
Stem Cell Reports|January 24, 2018
Isogenic FUS-eGFP iPSC Reporter Lines Enable Quantification of FUS Stress Granule Pathology that Is Rescued by Drugs Inducing AutophagyLara Marrone, Ina Poser, Ian Casci, et al.
Brain : a Journal of Neurology|February 28, 2026
Constitutive neuronal expression and disease-associated upregulation of chitinases in amyotrophic lateral sclerosisNayana Gaur, Christin Angerer, Zeynep I Gunes, et al.
Annals of Clinical and Translational Neurology|April 1, 2021
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatmentMaren Freigang, Claudia D Wurster, Tim Hagenacker, et al.
Cell Reports. Medicine|May 4, 2024
Targeting low levels of MIF expression as a potential therapeutic strategy for ALSLeenor Alfahel, Thomas Gschwendtberger, Velina Kozareva, et al.
Annals of Clinical and Translational Neurology|February 22, 2022
Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophyCamilla Binz, Alma Osmanovic, Nele H Thomas, et al.
Annals of Clinical and Translational Neurology|July 30, 2019
KCNC1-related disorders: new de novo variants expand the phenotypic spectrumJoohyun Park, Mahmoud Koko, Ulrike B S Hedrich, et al.
The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.
Stem Cells (Dayton, Ohio)|March 7, 2016
4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem CellsMaximilian Naujock, Nancy Stanslowsky, Sebastian Bufler, et al.
Journal of Neurology|May 6, 2018
Therapeutic decisions in ALS patients: cross-cultural differences and clinical implicationsPeter M Andersen, Magdalena Kuzma-Kozakiewicz, Jürgen Keller, et al.
Pageof 35